Literature DB >> 23652581

Intravitreal dexamethasone 0.7-mg implant for radiation macular edema after proton beam therapy for choroidal melanoma.

Stéphanie Baillif1, Celia Maschi, Pierre Gastaud, Jean Pierre Caujolle.   

Abstract

PURPOSE: To evaluate the efficacy of dexamethasone 0.7-mg intravitreal implant in patients with radiation macular edema after proton beam therapy for choroidal melanoma.
METHODS: Five patients' charts were retrospectively reviewed. The main outcome measures were visual acuity and mean central retinal thickness.
RESULTS: All patients received a radiation dose of 60 cobalt gray equivalent. Radiation macular edema occurred within a mean time of 26 months after irradiation. Mean preinjection visual acuity was 41 Early Treatment Diabetic Retinopathy Study letters. Mean central retinal thickness was 487.1 μm. Two months after injection, mean visual acuity was 47 Early Treatment Diabetic Retinopathy Study letters. It improved for 3 patients (+4, +9 and, +15 letters) and remained unchanged for 2. Mean central retinal thickness was 331 μm. It decreased for 4 patients (-111, -134, -336, and -187 μm). Two patients underwent a second injection of dexamethasone performed 5 months after the first injection. The gain of visual acuity was +8 and +23 letters with a decrease in central retinal thickness of 158 and 262 μm, respectively. Intraocular pressure increased for 1 patient over a mean follow-up period of 6.4 months.
CONCLUSION: Intravitreal dexamethasone implant can improve visual acuity in radiation macular edema. The observed beneficial effect lasted up to 5 months.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23652581     DOI: 10.1097/IAE.0b013e31829234fa

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  6 in total

1.  Ranibizumab for the Prevention of Radiation Complications in Patients Treated With Proton Beam Irradiation for Choroidal Melanoma.

Authors:  Ivana K Kim; Anne Marie Lane; Purva Jain; Caroline Awh; Evangelos S Gragoudas
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

Review 2.  Non-Cancer Effects following Ionizing Irradiation Involving the Eye and Orbit.

Authors:  Juliette Thariat; Arnaud Martel; Alexandre Matet; Olivier Loria; Laurent Kodjikian; Anh-Minh Nguyen; Laurence Rosier; Joël Herault; Sacha Nahon-Estève; Thibaud Mathis
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

Review 3.  Drug delivery implants in the treatment of vitreous inflammation.

Authors:  Jillian Wang; Angela Jiang; Malav Joshi; John Christoforidis
Journal:  Mediators Inflamm       Date:  2013-09-28       Impact factor: 4.711

4.  Long-term follow-up of anatomical and functional macular changes after a single intravitreal implant of dexamethasone 0.7 mg for radiation macular edema secondary to proton beam therapy for choroidal melanoma.

Authors:  Francesco Stringa; Federico Marzi; Laura Giannì; Manuela Imparato; Alessandro Bianchi; Paolo Emilio Bianchi
Journal:  Int Med Case Rep J       Date:  2016-11-30

Review 5.  Widening use of dexamethasone implant for the treatment of macular edema.

Authors:  Vincenza Bonfiglio; Michele Reibaldi; Matteo Fallico; Andrea Russo; Alessandra Pizzo; Stefano Fichera; Carlo Rapisarda; Iacopo Macchi; Teresio Avitabile; Antonio Longo
Journal:  Drug Des Devel Ther       Date:  2017-08-16       Impact factor: 4.162

6.  Transient reversal of macular ischemia with intravitreal steroid implant injection in a case of radiation maculopathy.

Authors:  Aditya Verma; Vikas Khetan
Journal:  Indian J Ophthalmol       Date:  2018-03       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.